Loading data for KNSA — first visit, this takes a few seconds.
Kiniksa Pharmaceuticals I... (KNSA)
NasdaqGS: KNSA
· Real-Time Price · USD
80.20
+0.82 (1.03%)
At close: Aug 28, 2026, 3:59 PM
79.63
+1.99%
After-hours: 7:49 PM
The price, the headline numbers and the latest news, in one place.
Kiniksa Pharmaceuticals International (KNSA) Stock Price, Analysis & Data
1.03% (1D)
| Bid | 57.45 |
| Market Cap | 6.09B |
| Revenue (ttm) | 840.85M |
| Net Income (ttm) | 80.66M |
| 0.09 | |
| 0.97 | |
| 80.49 | |
| 48.27 | |
| P/B (ttm) | 9.31 |
| P/S (ttm) | 7.14 |
| Earnings Date | Oct 27, 2026 |
| Ask | 102.19 |
| Volume | 402,049 |
| Avg. Volume (20D) | 749,639 |
| Open | 79.36 |
| Previous Close | 79.38 |
| Day's Range | 79.22 - 80.86 |
| 52-Week Range | 32.89 - 82.94 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About KNSA
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobul...
Sector Healthcare
IPO Date May 25, 2018
Employees 366
Stock Exchange NasdaqGS
Ticker Symbol KNSA
Website https://www.kiniksa.com
Financial Performance
In 2025, Kiniksa Pharmaceuticals International's revenue was 677.56M, an increase of 60.09% compared to the previous year's 423.24M. Earnings were 59.01M, a decrease of -236.61%.
Financial StatementsEarnings Surprise
Kiniksa Pharmaceuticals International has released their quarterly earnings on Jul 28, 2026:
- Revenue of $243.6M misses estimates by $0, with 55.36% YoY growth.
- EPS of 0.3 exceeds estimates by 0.02, with 30.43% YoY growth.
Kiniksa Pharmaceuticals International is scheduled to release its earnings on Oct 27, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2